| Pathological roles of MAPK signaling pathways in human diseases | 2010/04/01 | English | 1,589 |
| Nrf2 signaling pathway: Pivotal roles in inflammation | 2017/02/01 | English | 1,127 |
| Oxidative stress and mitochondrial dysfunction in Alzheimer's disease | 2014/08/01 | English | 847 |
| Biochemical, physiological and medical aspects of ubiquinone function | 1995/05/01 | English | 815 |
| Mitochondrial dysfunction and oxidative stress in metabolic disorders — A step towards mitochondria based therapeutic strategies | 2017/05/01 | English | 755 |
| Functions of plasmalogen lipids in health and disease | 2012/09/01 | English | 664 |
| Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach | 2020/10/01 | English | 628 |
| Tau pathology in Alzheimer disease and other tauopathies | 2005/01/01 | English | 606 |
| PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation | 2011/08/01 | English | 596 |
| miR-155 gene: A typical multifunctional microRNA | 2009/06/01 | English | 552 |
| Mast cells and inflammation | 2012/01/01 | English | 530 |
| Endothelial dysfunction — A major mediator of diabetic vascular disease | 2013/12/01 | English | 528 |
| Bioactivity and protective effects of natural carotenoids | 2005/05/01 | English | 502 |
| Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology | 2010/01/01 | English | 478 |
| Role of transforming growth factor-β superfamily signaling pathways in human disease | 2008/04/01 | English | 475 |
| The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives | 2014/08/01 | English | 471 |
| ROS/oxidative stress signaling in osteoarthritis | 2016/04/01 | English | 459 |
| Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance | 2014/03/01 | English | 454 |
| α-Synuclein misfolding and Parkinson's disease | 2012/02/01 | English | 447 |
| TGF-β and fibrosis in different organs — molecular pathway imprints | 2009/08/01 | English | 441 |
| Mitochondrial creatine kinase in human health and disease | 2006/02/01 | English | 426 |
| Mitochondria, oxidative metabolism and cell death in stroke | 2010/01/01 | English | 415 |
| Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease | 2017/05/01 | English | 393 |
| Mitochondrial dysfunction in Parkinson's disease | 2010/01/01 | English | 372 |
| Role of peroxisomes in ROS/RNS-metabolism: Implications for human disease | 2012/09/01 | English | 368 |
| Next generation sequencing technology: Advances and applications | 2014/10/01 | English | 365 |
| Alternative splicing and disease | 2009/01/01 | English | 355 |
| Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease | 2016/05/01 | English | 352 |
| Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal | 2017/05/01 | English | 345 |
| The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis | 2006/11/01 | English | 334 |